Glycogen Synthase Kinase 3: A Kinase for All Pathways?

Current Topics in Developmental Biology

Volumn 123, Issue , 2017, Pages 277-302

  Patel, Prital ^a   Woodgett, James R ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Alzheimer's; Hedgehog; Insulin; Notch; Signal transduction; TGFbeta; Wnt

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3; ISOENZYME;

AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; HUMAN; METABOLISM; MOLECULARLY TARGETED THERAPY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISOENZYMES; MODELS, BIOLOGICAL; MOLECULAR TARGETED THERAPY; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 85009348240     PISSN: 00702153     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.ctdb.2016.11.011     Document Type: Chapter

References (86)

1. Ali, A., Hoeflich, K.P., Woodgett, J.R., Glycogen synthase kinase-3: Properties, functions, and regulation. Chemical Reviews 101 (2001), 2527–2540.
2. Alon, L.T., Pietrokovski, S., Barkan, S., Avrahami, L., Kaidanovich-Beilin, O., Woodgett, J.R., et al. Selective loss of glycogen synthase kinase-3alpha in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation. FEBS Letters 585 (2011), 1158–1162.
3. Aplin, A.E., Gibb, G.M., Jacobsen, J.S., Gallo, J.M., Anderton, B.H., In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta. Journal of Neurochemistry 67 (1996), 699–707.
4. Bax, B., Carter, P.S., Lewis, C., Guy, A.R., Bridges, A., Tanner, R., et al. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation. Structure 9 (2001), 1143–1152.
5. Bianchi, M.W., Plyte, S.E., Kreis, M., Woodgett, J.R., A Saccharomyces cerevisiae protein-serine kinase related to mammalian glycogen synthase kinase-3 and the Drosophila melanogaster gene shaggy product. Gene 134 (1993), 51–56.
6. Bourouis, M., Moore, P., Ruel, L., Grau, Y., Heitzler, P., Simpson, P., An early embryonic product of the gene shaggy encodes a serine/threonine protein kinase related to the CDC28/cdc2 + subfamily. The EMBO Journal 9 (1990), 2877–2884.
7. Bouskila, M., Hunter, R.W., Ibrahim, A.F., Delattre, L., Peggie, M., van Diepen, J.A., et al. Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metabolism 12 (2010), 456–466.
8. Cheng, K., Creacy, S., Larner, J., ‘Insulin-like’ effects of lithium ion on isolated rat adipocytes. II. Specific activation of glycogen synthase. Molecular and Cellular Biochemistry 56 (1983), 183–189.
9. Cline, G.W., Johnson, K., Regittnig, W., Perret, P., Tozzo, E., Xiao, L., et al. Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51 (2002), 2903–2910.
10. Coghlan, M.P., Culbert, A.A., Cross, D.A., Corcoran, S.L., Yates, J.W., Pearce, N.J., et al. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chemistry & Biology 7 (2000), 793–803.
11. Cohen, P., Goedert, M., GSK3 inhibitors: Development and therapeutic potential. Nature Reviews. Drug Discovery 3 (2004), 479–487.
12. Cohen, P., Yellowlees, D., Aitken, A., Donella-Deana, A., Hemmings, B.A., Parker, P.J., Separation and characterisation of glycogen synthase kinase 3, glycogen synthase kinase 4 and glycogen synthase kinase 5 from rabbit skeletal muscle. European Journal of Biochemistry 124 (1982), 21–35.
13. Cole, A., Frame, S., Cohen, P., Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. The Biochemical Journal 377 (2004), 249–255.
14. Cross, D.A., Alessi, D.R., Cohen, P., Andjelkovich, M., Hemmings, B.A., Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378 (1995), 785–789.
15. Dajani, R., Fraser, E., Roe, S.M., Yeo, M., Good, V.M., Thompson, V., et al. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex. The EMBO Journal 22:3 (2003), 494–501.
16. Dajani, R., Fraser, E., Roe, S.M., Young, N., Good, V., Dale, T.C., et al. Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105:6 (2001), 721–732.
17. De Sarno, P., Li, X., Jope, R.S., Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. Neuropharmacology 43:7 (2002), 1158–1164.
18. del Ser, T., Steinwachs, K.C., Gertz, H.J., Andres, M.V., Gomez-Carrillo, B., Medina, M., et al. Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: A pilot study. Journal of Alzheimer's Disease 33:1 (2013), 205–215.
19. Demagny, H., Araki, T., De Robertis, E.M., The tumor suppressor Smad4/DPC4 is regulated by phosphorylations that integrate FGF, Wnt, and TGF-beta signaling. Cell Reports 9:2 (2014), 688–700.
20. Dembowy, J., Adissu, H.A., Liu, J.C., Zacksenhaus, E., Woodgett, J.R., Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis. Oncogene 34:27 (2015), 3514–3526.
21. Diaz-Benjumea, F.J., Cohen, S.M., wingless acts through the shaggy/zeste-white 3 kinase to direct dorsal-ventral axis formation in the Drosophila leg. Development 120:6 (1994), 1661–1670.
22. Doble, B.W., Patel, S., Wood, G.A., Kockeritz, L.K., Woodgett, J.R., Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Developmental Cell 12:6 (2007), 957–971.
23. Dominguez, I., Itoh, K., Sokol, S.Y., Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos. Proceedings of the National Academy of Sciences of the United States of America 92:18 (1995), 8498–8502.
24. Eldar-Finkelman, H., Martinez, A., GSK-3 inhibitors: Preclinical and clinical focus on CNS. Frontiers in Molecular Neuroscience, 4, 2011, 32.
25. Eldar-Finkelman, H., Schreyer, S.A., Shinohara, M.M., LeBoeuf, R.C., Krebs, E.G., Increased glycogen synthase kinase-3 activity in diabetes- and obesity-prone C57BL/6J mice. Diabetes 48:8 (1999), 1662–1666.
26. Eldar-Finkelman, H., Seger, R., Vandenheede, J.R., Krebs, E.G., Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. The Journal of Biological Chemistry 270:3 (1995), 987–990.
27. Embi, N., Rylatt, D.B., Cohen, P., Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase. European Journal of Biochemistry 107:2 (1980), 519–527.
28. Espinosa, L., Ingles-Esteve, J., Aguilera, C., Bigas, A., Phosphorylation by glycogen synthase kinase-3 beta down-regulates Notch activity, a link for Notch and Wnt pathways. The Journal of Biological Chemistry 278:34 (2003), 32227–32235.
29. Fiol, C.J., Mahrenholz, A.M., Wang, Y., Roeske, R.W., Roach, P.J., Formation of protein kinase recognition sites by covalent modification of the substrate. Molecular mechanism for the synergistic action of casein kinase II and glycogen synthase kinase 3. The Journal of Biological Chemistry 262:29 (1987), 14042–14048.
30. Foltz, D.R., Santiago, M.C., Berechid, B.E., Nye, J.S., Glycogen synthase kinase-3beta modulates notch signaling and stability. Current Biology: CB 12:12 (2002), 1006–1011.
31. Greene, M.W., Garofalo, R.S., Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 41:22 (2002), 7082–7091.
32. Guo, X., Ramirez, A., Waddell, D.S., Li, Z., Liu, X., Wang, X.F., Axin and GSK3-control Smad3 protein stability and modulate TGF-signaling. Genes & Development 22:1 (2008), 106–120.
33. Hampel, H., Ewers, M., Burger, K., Annas, P., Mortberg, A., Bogstedt, A., et al. Lithium trial in Alzheimer's disease: A randomized, single-blind, placebo-controlled, multicenter 10-week study. The Journal of Clinical Psychiatry 70:6 (2009), 922–931.
34. Han, X., Ju, J.H., Shin, I., Glycogen synthase kinase 3-beta phosphorylates novel S/T-P-S/T domains in Notch1 intracellular domain and induces its nuclear localization. Biochemical and Biophysical Research Communications 423:2 (2012), 282–288.
35. Hanger, D.P., Anderton, B.H., Noble, W., Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends in Molecular Medicine 15:3 (2009), 112–119.
36. Hardy, J.A., Higgins, G.A., Alzheimer's disease: The amyloid cascade hypothesis. Science 256:5054 (1992), 184–185.
37. Hartigan, J.A., Xiong, W.C., Johnson, G.V., Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochemical and Biophysical Research Communications 284:2 (2001), 485–489.
38. Harwood, A.J., Plyte, S.E., Woodgett, J., Strutt, H., Kay, R.R., Glycogen synthase kinase 3 regulates cell fate in Dictyostelium. Cell 80:1 (1995), 139–148.
39. He, X., Saint-Jeannet, J.P., Woodgett, J.R., Varmus, H.E., Dawid, I.B., Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos. Nature 374:6523 (1995), 617–622.
40. Henriksen, E.J., Kinnick, T.R., Teachey, M.K., O'Keefe, M.P., Ring, D., Johnson, K.W., et al. Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats. American Journal of Physiology. Endocrinology and Metabolism 284:5 (2003), E892–E900.
41. Hoeflich, K.P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O., Woodgett, J.R., Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406:6791 (2000), 86–90.
42. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., Spiegelman, B.M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271:5249 (1996), 665–668.
43. Hughes, K., Nikolakaki, E., Plyte, S.E., Totty, N.F., Woodgett, J.R., Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. The EMBO Journal 12:2 (1993), 803–808.
44. Jin, Y.H., Kim, H., Oh, M., Ki, H., Kim, K., Regulation of Notch1/NICD and Hes1 expressions by GSK-3alpha/beta. Molecules and Cells 27:1 (2009), 15–19.
45. Jones, K., Wei, C., Iakova, P., Bugiardini, E., Schneider-Gold, C., Meola, G., et al. GSK3β mediates muscle pathology in myotonic dystrophy. The Journal of Clinical Investigation 122:12 (2012), 4461–4472.
46. Kerkela, R., Kockeritz, L., Macaulay, K., Zhou, J., Doble, B.W., Beahm, C., et al. Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation. The Journal of Clinical Investigation 118:11 (2008), 3609–3618.
47. Kim, W.Y., Wang, X., Wu, Y., Doble, B.W., Patel, S., Woodgett, J.R., et al. GSK-3 is a master regulator of neural progenitor homeostasis. Nature Neuroscience 12:11 (2009), 1390–1397.
48. Kirshenboim, N., Plotkin, B., Shlomo, S.B., Kaidanovich-Beilin, O., Eldar-Finkelman, H., Lithium-mediated phosphorylation of glycogen synthase kinase-3beta involves PI3 kinase-dependent activation of protein kinase C-alpha. Journal of Molecular Neuroscience 24:2 (2004), 237–245.
49. Klein, P.S., Melton, D.A., A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 93:16 (1996), 8455–8459.
50. Larner, J., Villar-Palasi, C., Goldberg, N.D., Bishop, J.S., Huijing, F., Wenger, J.I., et al. Hormonal and non-hormonal control of glycogen synthesis-control of transferase phosphatase and transferase I kinase. Advances in Enzyme Regulation 6 (1968), 409–423.
51. Lau, K.F., Miller, C.C., Anderton, B.H., Shaw, P.C., Expression analysis of glycogen synthase kinase-3 in human tissues. The Journal of Peptide Research 54:1 (1999), 85–91.
52. Lesort, M., Jope, R.S., Johnson, G.V., Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. Journal of Neurochemistry 72:2 (1999), 576–584.
53. Li, T., Hawkes, C., Qureshi, H.Y., Kar, S., Paudel, H.K., Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. Biochemistry 45:10 (2006), 3134–3145.
54. Liberman, Z., Eldar-Finkelman, H., Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling. The Journal of Biological Chemistry 280:6 (2005), 4422–4428.
55. Licht-Murava, A., Paz, R., Vaks, L., Avrahami, L., Plotkin, B., Eisenstein, M., et al. A unique type of GSK-3 inhibitor brings new opportunities to the clinic. Science Signaling, 9, 2016, ra110.
56. Linding, R., Jensen, L.J., Ostheimer, G.J., van Vugt, M.A.T.M., Jørgensen, C., Miron, I.M., et al. Systematic discovery of in vivo phosphorylation networks. Cell 129:7 (2007), 1415–1426.
57. Lochhead, P.A., Kinstrie, R., Sibbet, G., Rawjee, T., Morrice, N., Cleghon, V., A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation. Molecular Cell 24:4 (2006), 627–633.
58. Logan, C.Y., Nusse, R., The Wnt signaling pathway in development and disease. Annual Review of Cell and Developmental Biology 20 (2004), 781–810.
59. MacAulay, K., Doble, B.W., Patel, S., Hansotia, T., Sinclair, E.M., Drucker, D.J., et al. Glycogen synthase kinase 3alpha-specific regulation of murine hepatic glycogen metabolism. Cell Metabolism 6:4 (2007), 329–337.
60. Macdonald, A., Briggs, K., Poppe, M., Higgins, A., Velayudhan, L., Lovestone, S., A feasibility and tolerability study of lithium in Alzheimer's disease. International Journal of Geriatric Psychiatry 23:7 (2008), 704–711.
61. Meijer, L., Flajolet, M., Greengard, P., Pharmacological inhibitors of glycogen synthase kinase 3. Trends in Pharmacological Sciences 25:9 (2004), 471–480.
62. Morfini, G., Szebenyi, G., Elluru, R., Ratner, N., Brady, S.T., Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. The EMBO Journal 21:3 (2002), 281–293.
63. Mukai, F., Ishiguro, K., Sano, Y., Fujita, S.C., Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta. Journal of Neurochemistry 81:5 (2002), 1073–1083.
64. Nikoulina, S.E., Ciaraldi, T.P., Mudaliar, S., Carter, L., Johnson, K., Henry, R.R., Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes 51:7 (2002), 2190–2198.
65. Parker, P.J., Caudwell, F.B., Cohen, P., Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo. European Journal of Biochemistry 130:1 (1983), 227–234.
66. Patel, S., Doble, B.W., MacAulay, K., Sinclair, E.M., Drucker, D.J., Woodgett, J.R., Tissue-specific role of glycogen synthase kinase 3beta in glucose homeostasis and insulin action. Molecular and Cellular Biology 28:20 (2008), 6314–6328.
67. Patel, S., Macaulay, K., Woodgett, J.R., Tissue-specific analysis of glycogen synthase kinase-3alpha (GSK-3alpha) in glucose metabolism: Effect of strain variation. PLoS One, 6(1), 2011, e15845.
68. Pearce, N.J., Arch, J.R., Clapham, J.C., Coghlan, M.P., Corcoran, S.L., Lister, C.A., et al. Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoter. Metabolism 53:10 (2004), 1322–1330.
69. Planas-Paz, L., Orsini, V., Boulter, L., Calabrese, D., Pikiolek, M., Nigsch, F., et al. The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nature Cell Biology 18:5 (2016), 467–479.
70. Plotkin, B., Kaidanovich, O., Talior, I., Eldar-Finkelman, H., Insulin mimetic action of synthetic phosphorylated peptide inhibitors of glycogen synthase kinase-3. The Journal of Pharmacology and Experimental Therapeutics 305:3 (2003), 974–980.
71. Plyte, S.E., Hughes, K., Nikolakaki, E., Pulverer, B.J., Woodgett, J.R., Glycogen synthase kinase-3: Functions in oncogenesis and development. Biochimica Biophysica Acta 1114:2–3 (1992), 147–162.
72. Price, M.A., Calderon, D., Proteolysis of the hedgehog signaling effector cubitus interruptus requires phosphorylation by glycogen synthase kinase 3 and casein kinase 1. Cell 108:6 (2002), 823–835.
73. Ring, D.B., Johnson, K.W., Henriksen, E.J., Nuss, J.M., Goff, D., Kinnick, T.R., et al. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52:3 (2003), 588–595.
74. Ryan, K.A., Pimplikar, S.W., Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. The Journal of Cell Biology 171:2 (2005), 327–335.
75. Siegfried, E., Perkins, L.A., Capaci, T.M., Perrimon, N., Putative protein kinase product of the Drosophila segment-polarity gene zeste-white3. Nature 345:6278 (1990), 825–829.
76. Stambolic, V., Ruel, L., Woodgett, J.R., Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology: CB 6:12 (1996), 1664–1668.
77. Su, Y., Ryder, J., Li, B., Wu, X., Fox, N., Solenberg, P., et al. Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. Biochemistry 43:22 (2004), 6899–6908.
78. Sutherland, C., What are the bona fide GSK3 substrates?. International Journal of Alzheimer's Disease, 2011, 2011, 505607.
79. Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., et al. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proceedings of the National Academy of Sciences of the United States of America 95:16 (1998), 9637–9641.
80. Tempe, D., Casas, M., Karas, S., Blanchet-Tournier, M.F., Concordet, J.P., Multisite protein kinase A and glycogen synthase kinase 3beta phosphorylation leads to Gli3 ubiquitination by SCFbetaTrCP. Molecular and Cellular Biology 26:11 (2006), 4316–4326.
81. ter Haar, E., Coll, J.T., Austen, D.A., Hsiao, H.M., Swenson, L., Jain, J., Structure of GSK3beta reveals a primed phosphorylation mechanism. Nature Structural Biology 8:7 (2001), 593–596.
82. Voskas, D., Ling, L.S., Woodgett, J.R., Does GSK-3 provide a shortcut for PI3K activation of Wnt signaling?. F1000 Biology Reports, 2, 2010, 82.
83. White, M.F., Maron, R., Kahn, C.R., Insulin rapidly stimulates tyrosine phosphorylation of a Mr-185,000 protein in intact cells. Nature 318:6042 (1985), 183–186.
84. Woodgett, J.R., Molecular cloning and expression of glycogen synthase kinase-3/factor A. The EMBO Journal 9:8 (1990), 2431–2438.
85. Yao, H.B., Shaw, P.C., Wong, C.C., Wan, D.C., Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. Journal of Chemical Neuroanatomy 23:4 (2002), 291–297.
86. Zhang, F., Phiel, C.J., Spece, L., Gurvich, N., Klein, P.S., Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3. The Journal of Biological Chemistry 278 (2003), 33067–33077.